CryoPort, Inc.

CYRX | $16.11 -2.19% -2.23% 510K

(0.0% 1d) (6.1% 1m) (-20.3% 1y) (0.0% 2d) (0.0% 3d) (-0.1% 7d) (-21.18% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 792,039,741
http://www.cryoport.com
Sec Filling | Patents | 125 employees

(US) CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

vaccine stem cell immunotherapy cryo car-t t-cell diagnostics ceiling

add to watch list Paper trade email alert is off